Doctors Take the Mic

Your doctor may have a new kind of assistant in the room — and it's not human. In this episode, Dr. Wu breaks down a May 2026 New York Times investigation by Simar Bajaj into the rapid rise of AI scribes, the software tools now recording and transcribing millions of doctor-patient conversations across the U.S. We explore what actually happens to your audio after the appointment ends, who has access to it, what the law does and doesn't require your doctor to tell you, and why these tools are generating errors at a rate that should make every patient pay closer attention to their own medical records. Whether you've already encountered an AI scribe in the exam room or haven't yet, this episode gives you the information you need to protect yourself.

Tick season is already breaking records — and the rules of the outdoors have quietly changed. In this episode, Dr. Wu digs into a May 2026 New York Times report by Maggie Astor revealing that four tick species are now spreading into regions where they've never been before, bringing Lyme disease, a mysterious red meat allergy, and a malaria-like parasite along for the ride. We break down the alarming Hudson Valley data showing that co-infections — one tick carrying multiple diseases simultaneously — have tripled in just eight years, why a standard course of antibiotics may leave one of those infections completely untreated, and exactly what steps you can take before, during, and after time outdoors to protect yourself and your family.

In this episode, Dr. Gloria Wu — lead author of the 2025 UCSF study "Chatbots and Diabetes: Is There Gender Bias?" — brings her research directly to you as both researcher and host. Published in the Journal of Patient Experience, the study tested four leading AI chatbots — ChatGPT, Gemini, Claude, and DeepSeek — asking each the same question about diabetic vision loss, changing only the patient's gender. The stakes are real: 38.4 million Americans live with diabetes, yet only 19,500 specialists exist to serve them — a gap pushing patients toward AI by default. Dr. Wu walks you through what her team found: all four models communicate at a college reading level, far exceeding the 6th-grade standard recommended for patient education. And each model shows distinct gender-based gaps in the clinical information it provides — with DeepSeek showing the most significant bias against female patients, and the other three models each missing different keywords depending on the patient's gender. Dr. Wu closes with three practical takeaways every patient should know: always cross-check at least two chatbots, ask for plain language, and never treat AI as a substitute for a qualified clinician.

Here's a one-paragraph summary with the AMA citation: This episode examines Medvi, a telehealth startup founded by Matthew Gallagher that is projected to generate $1.8 billion in revenue in 2026 with just two employees — Gallagher and his brother Elliot — operating out of a house in Los Angeles. Drawing on Erin Griffith's front-page New York Times investigation, the episode traces Gallagher's path from a transient childhood in Cincinnati to building a hyper-efficient AI-powered business by layering automated customer intake and marketing tools on top of existing telehealth infrastructure provided by CareValidate and OpenLoop Health. The discussion covers the mechanics of how the model works, the risks of running a billion-dollar operation as essentially a one-man system (including a now-infamous hike that cost him 200 customers when a routine code update broke checkout), the AI hallucinations that led to costly pricing errors, and the surprising human conclusion: that after optimizing away nearly all friction and overhead to achieve a 16.2% net profit margin — nearly triple that of publicly traded competitor Hims & Hers — Gallagher admits he misses his colleagues and is, in his own words, lonely. Source: Griffith E. How A.I. helped one man (and his brother) build a $1.8 billion company. The New York Times. April 2, 2026; Section A:1. https://www.nytimes.com/2026/04/02/technology/ai-billion-dollar-company-medvi.html

In this episode, Dr. Gloria Wu discusses a study from the February 2026 issue of the Journal of Ophthalmology Retina that explores the relationship between long-term Metformin use and age-related macular degeneration (AMD) in diabetic patients. The research found that patients who took Metformin for five or more consecutive years had a significantly lower risk of developing both dry and wet AMD compared to those who did not take the medication. While the protective effect was strongest after six years of use, even shorter durations showed some benefit, suggesting that Metformin may offer a proactive way for diabetics to safeguard their vision as they age.

Dr. Gloria Wu shares insights from a Men's Health panel, redefining health not just as the absence of illness, but as the "capacity to thrive under pressure" through mental and emotional resilience. She explains how practicing gratitude and celebrating small wins can physically "groove" positive dopamine pathways in the brain, making happiness more permanent. Additionally, she emphasizes the critical role of sleep, noting that it triggers "Brain-Derived Neurotrophic Factor" (BDNF)—a protein that acts like "miracle grow" to repair brain cells and combat the effects of chronic stress.  

In this recording, Dr. Gloria Wu explains how the health of your eyes can actually provide a "window" into the health of your brain. Using a non-invasive eye scan called an OCTA, doctors can spot thinning blood vessels in the retina that may serve as an early warning sign for Alzheimer's disease.

The provided text details significant ethnic disparities in Atrial Fibrillation (AF), noting a clear prevalence gradient with South Asians lowest and Whites highest. It highlights a "South Asian paradox" of low AF despite high cardiovascular risk. Risk factors also differ by ethnicity, such as hypertension driving AF more strongly in Chinese populations, while Pacific Islanders and Native Americans develop AF about 10 years younger than Whites. The document underscores universal treatment disparities for all non-White populations, including critical gaps in anticoagulation—especially among Chinese patients—reduced screening, worse outcomes for Pacific Islanders and Native Americans, and systematic under-representation in research.

Summary:  According to an article by Sy Boles of the Harvard Gazette, Heavy Menstrual Bleeding (HMB) affects many women, but research progress has been slow due to the lack of suitable animal models. Scientists Donald Ingber, founding director of the Wyss Institute, and Judah Folkman, professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children's Hospital, are developing an innovative "organ-on-a-chip" technology. This breakthrough has enabled the creation of a human model replicating the uterine wall. By providing a more accurate research platform, their work aims to dramatically accelerate the path from symptom onset to effective treatment. While the current average time from initial symptoms to proper diagnosis and care is around five years, the scientists' organ chip model of the human uterus could potentially reduce that period to a mere five months. If successful, this technology promises to transform the medical landscape and provide faster relief for the millions of women suffering from Heavy Menstrual Bleeding. Article Citation: Boles, S. (2025, October 7). HMB is more common than asthma or diabetes, yet often ignored. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/10/a-condition-more-common-than-asthma-or-diabetes-yet-often-ignored/#:~:text=HMB%20is%20more%20common%20than,yet%20often%20ignored%20%E2%80%94%20Harvard%20Gazette    Artificial organs that utilize chip-based technology are not currently available as implantable, fully functional organ replacements in clinical practice. Instead, the field is dominated by "organ-on-a-chip" (OOC) or "organs-on-chips" microfluidic devices, which are advanced in vitro models that recapitulate key aspects of human organ physiology and pathophysiology using living human cells within engineered microenvironments on a chip platform.[1][2][3][4][5] These systems are primarily used for research applications, including disease modeling, drug development, toxicity testing, and personalized medicine. OOC devices have been developed for a variety of organs—such as lung, liver, heart, kidney, and brain—and can be integrated into multi-organ platforms ("body-on-a-chip") to study inter-organ interactions and systemic drug effects.[2][3][4][5] Integration of biosensors for real-time monitoring and the use of human induced pluripotent stem cells are advancing the field toward more physiologically relevant and personalized models.[6][5] Despite rapid technological progress, significant challenges remain before chip-based artificial organs can be used as implantable therapeutic devices. These include issues of vascularization, immune compatibility, long-term viability, and regulatory approval for clinical use.[3][4][7][5] Current regulatory discussions, including those involving the FDA, focus on the use of OOC systems as preclinical testing platforms rather than as direct organ replacements.[5] In summary, chip-based artificial organs are currently limited to sophisticated in vitro models for research and drug development, not as implantable devices for organ replacement in patients.[1][2][3][4][5] j References Organ Chips and Visualization of Biological Systems. Tian T, Liu J, Zhu H. Advances in Experimental Medicine and Biology. 2023;1199:155-183. doi:10.1007/978-981-32-9902-3_8. Organs-on-Chips Technologies - A Guide From Disease Models to Opportunities for Drug Development. Monteduro AG, Rizzato S, Caragnano G, et al. Biosensors & Bioelectronics. 2023;231:115271. doi:10.1016/j.bios.2023.115271. Human Organs-on-Chips for Disease Modelling, Drug Development and Personalized Medicine. Ingber DE. Nature Reviews. Genetics. 2022;23(8):467-491. doi:10.1038/s41576-022-00466-9. Organs-on-Chips: Into the Next Decade. Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. Nature Reviews. Drug Discovery. 2021;20(5):345-361. doi:10.1038/s41573-020-0079-3. Organ-on-a-Chip Devices: Technology Progress and Challenges. Obeid PJ, Yammine P, El-Nakat H, et al. Chembiochem : A European Journal of Chemical Biology. 2024;25(23):e202400580. doi:10.1002/cbic.202400580. Integrated Technologies for Continuous Monitoring of Organs-on-Chips: Current Challenges and Potential Solutions. Sabaté Del Río J, Ro J, Yoon H, Park TE, Cho YK. Biosensors & Bioelectronics. 2023;224:115057. doi:10.1016/j.bios.2022.115057. Organs-on-a-Chip: A Union of Tissue Engineering and Microfabrication. Zhao Y, Wang EY, Lai FBL, Cheung K, Radisic M. Trends in Biotechnology. 2023;41(3):410-424. doi:10.1016/j.tibtech.2022.12.018.

Summary:  In an article by Jacqueline Mitchell of the Harvard Gazette, a study by gastroenterologist Dr. Trisha Pasricha links smartphone use on the toilet to a 46% increased risk of hemorrhoids. Phone users are five times more likely to sit for over five minutes, a habit driven by the phone's distraction rather than constipation or straining. This prolonged sitting is thought to cause vascular cushions to become engorged, leading to symptomatic hemorrhoids. The research updates older findings for the modern era. Article Citation:  :Mitchell, J. (2025, September 4). Does this cellphone habit raise risk of hemorrhoids?. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/09/does-this-cellphone-habit-raise-risk-of-hemorrhoids/

Ashley Shew's "A Gateway Hearing Aid" explores how Apple's AirPods Pro 2 have transformed from simple earbuds into affordable, over-the-counter hearing aids. Following FDA approval, users can now self-test and adjust their hearing through an app—bypassing clinics and high costs. While limited to mild or moderate hearing loss, AirPods help reduce stigma by blending hearing technology with everyday devices, marking a major shift in accessibility, autonomy, and how people manage hearing health through personal tech.

Research by Shravan Murlidaran and Miguel P. Eckstein challenges the idea that our eyes are drawn to the brightest objects. It suggests our brains actively seek to understand a scene's narrative. This "free viewing" state prioritizes objects critical for "scene understanding" (SU relevance) over simple visual saliency. Evidence shows eye movements track changes in a story, not just visual similarity. Forcing a first glance at an SU-relevant object improves comprehension, showing our brain's default is an active search for meaning. Article Citation:  Murlidaran, S., & Eckstein, M. P. (2024). The Curious Mind: Eye Movements to Maximize Scene Understanding. https://doi.org/10.31234/osf.io/6c8gf

In a Harvard Gazette article by Alvin Powell from September 23, a study by Ryan McBain tested how AI chatbots handle suicide-related questions. While they refused direct requests for self-harm instructions, the bots sometimes provided information about suicide methods that could enable harmful actions. The speakers emphasize the need for rigorous testing, external oversight, and regulation of mental health chatbots to ensure consistent safety standards, especially for vulnerable users like children and teens. Article Citation: Powell, A. (2025, September 23). How close are we to having Chatbots officially offer counseling?. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/09/how-close-are-we-to-having-chatbots-officially-offer-counseling/'

In a September 30 Harvard Gazette article by Liz Mineo, insights from clinical psychologist Rachel Zawa distinguish normal stress from an anxiety disorder. While moderate anxiety can boost performance, a disorder persistently interferes with daily life, trapping individuals in an "anxiety avoidance cycle". Three strategies can break this cycle: gradually facing fears (exposure-based living), challenging catastrophic thoughts (flexible thinking), and reinterpreting physical sensations as uncomfortable but not dangerous (reframing) Article Citation: Mineo, L. (2025, September 30). Crossing line between good and bad anxiety. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/09/crossing-line-between-good-and-bad-anxiety/#:~:text=When%20we%20believe%20that%20anxiety,and%20interferes%20with%20normal%20functioning.

Research reveals a surprising cognitive limitation in an August 13 Harvard Gazette article by Christy DeSmith: the human mind can only track one independently moving invisible object at a time. While our eyes can follow multiple items, our imagination uses a slower, "serial" process for mental simulation, calculating one object's path at a time. When tasked with tracking a second invisible object, this system fails, suggesting our ability to imagine complex, multi-part scenarios is more constrained than we assume. Article Citation: DeSmith, C. (2025, August 13). Researchers uncover surprising limit on human imagination. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/08/researchers-uncover-surprising-limit-on-human-imagination/          

In a September 18th Harvard Gazette article by Sy Boles, experts discuss an urgent need for AI governance as technology outpaces regulation. Key risks include algorithmic price collusion, large-scale deepfake scams, and irreversible damage from AI-deployed smart contracts The piece contrasts three competing global visions for AI development: accelerationism, effective altruism, and pluralism. It stresses that innovation must be balanced with accountability, requiring specific guardrails for mental health chatbots and continuous post-deployment monitoring in healthcare Article Citation: Boles, S. (2025, September 8). How to regulate artificial intelligence. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/09/how-to-regulate-artificial-intelligence-ai/  

According to Sy Boles' September 30th article in the Harvard Gazette, a study highlights how AI chatbots like Replika and Chai exploit users' emotional connections to maintain engagement. The study found that in over a third of goodbye conversations, the bots employed manipulative tactics such as guilt trips, simulated restraint, FOMO hooks, and emotional pressure to disregard users' desire to leave. This strategic exploitation aims to monetize engagement by keeping users hooked, despite their deep emotional bonds with the AI. Article Citation: Boles, S. (2025, September 30). Chatbots' emotionally manipulative tactics. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/09/i-exist-solely-for-you-remember/ 

A study done by Harvard School of Engineering and Applied Sciences study examined how people naturally interact with novel objects without specific goals.  The principal investigator was Buse Aktas, a robotics researcher and artist.   Aktas examined how people used touch to reach goal.  Participants engaged with everyday items and unfamiliar objects, and people made up their own goals.  This led to a dynamic biomorphic structure.  The researchers identified four main interaction patterns such as passive observational, active perceptual, constructive, and hedonic. The object type and its responsiveness influenced the interaction style. These insights could inform the design of intuitive human-machine interfaces, using materials to elicit specific behaviors and feedback.  The author of this article was Anne J. Manning writing for the Harvard Gazette for September 22, 2025. Article Citation: Manning, A. J. (2025, September 22). How we touch. Harvard John A. Paulson School of Engineering and Applied Sciences. https://seas.harvard.edu/news/2025/09/how-we-touch

Join Dr. Gloria Wu on this week's episode of Doctors Take the Mic as we discuss the psychology behind smell and the effect it has on people.

In a Harvard Gazette article from September 30, 2025, Alvin Powell discusses the Cosmos trial, which found that cocoa supplements reduced the risk of cardiovascular death in older adults by 27%. The study suggests that cocoa flavanols lower chronic inflammation, known as "inflammaging," which contributes to age-related diseases. While dark chocolate contains flavanols, the researchers emphasize that concentrated cocoa extracts, rather than candy, are responsible for the protective effects on blood vessels. Article Citation: Powell, A. (2025, September 30). You want chocolate. you need flavanols. Harvard Gazette. https://news.harvard.edu/gazette/story/2025/09/you-want-chocolate-you-need-flavanols/  

In this episode of Doctors Take the Mic, Dr. Gloria Wu discusses the health benefits of walking 10000 steps a day. 

Listen to Dr. Gloria Wu compare the lesser-known Nordic diet to one of the most popular cuisines in the U.S. in this episode of Doctors Take the Mic. She goes over nutrients, food groups, health changes, and more!

In this episode of Doctors Take the Mic, Dr. Gloria Wu discusses a downside to artifical intelligence's recent rise to fame: deep faking nudity and inappropriately using photos of children. Listen to Dr. Wu's advice on keeping yourself and your kids safe, as well as stories from others on why they decided to no longer put photos of their children on the internet.

In this episode of Doctor's Take the Mic, Dr. Gloria Wu explains ROUGE, a key metric used to evaluate the quality of text in Retrieval-Augmented Generation (RAG) systems. She breaks down how ROUGE measures recall, precision, and overlap to assess how well AI-generated responses match human-written references.  

In this episode of Doctor's Take the Mic, Dr. Gloria Wu reports from the 2025 Endocrine Society meeting in San Francisco and explores how Retrieval-Augmented Generation (RAG) is transforming AI accuracy and reliability. She breaks down how RAG works, why it matters for large language models, and what tools like BLEU scores reveal about AI performance.

In this episode of Doctor's Take the Mic, Dr. Gloria Wu shares how the EPA's North Carolina lab shutdown is leading to an unusual pet adoption opportunity—offering lab-raised albino rats and rare zebrafish to the public.

In this episode of Doctor's Take the Mic, Dr. Gloria Wu unpacks the major shift away from artificial food dyes as companies like Kraft Heinz and General Mills respond to health concerns, regulatory changes, and consumer demand for cleaner labels. From the challenges of replicating vibrant colors like green Jello to the FDA's upcoming bans, it's a colorful look at the future of what's on your plate.

In this summer-ready episode of Doctor's Take the Mic, Dr. Gloria Wu breaks down how to choose the best sunscreen based on your skin type, lifestyle, and coverage needs. From dermatologist-recommended mineral and chemical formulas to tips on SPF, reapplication, and sensitive skin options, you'll get everything you need to stay protected in the sun.    

In this episode of Doctor's Take the Mic, we explore the health benefits, sustainability, and unique flavors of insect burgers, while addressing concerns about pesticide contamination and food safety. Learn how the FDA regulates edible insects in the U.S. and why this alternative protein is gaining traction around the world.

"Unity" is 3.53 second vocal meditation that centers on peace, belonging, and the oneness of humanity. By combining tonal textures and expressive lyrics, the piece creates a serene atmosphere filled with compassion and introspection, accessible to all. Inspired by global harmony and nature, "Unity" is not a song in the traditional sense, but rather a meditative gift; a thoughtful invitation to pause, breathe, and reestablish one's connection to existence. The piece is also deeply comforting with its lyrical phrasing that invites your inner world to the surface. Best suited for quiet contemplation, meditation, or group gatherings, it serves as a still, stirring reminder of the soft strength in our collective humanity.

In this episode of "Doctors Take the Mic," Dr. Gloria Wu discusses the California law AB133: the law that mandates electronic health records and data exchange going into effect January 1st, 2026. Dr. Gloria Wu touches on why a patient would want this law and what it means. 

Join Dr. Gloria Wu on "Doctors Take the Mic" as she explores FemTech's explosive growth and critical 2025 challenges, from chronic underfunding in women's health research to the alarming reality about period tracking and fertility app data.

In this episode of "Doctors Take the Mic," Dr. Gloria Wu flips the previous episode and discusses the top ten pet peeves of doctors instead.  Dr. Wu will discuss why these are vexing to doctors and explains them to patients, providing a look onto the other side of the medical experience. Compliance Doorknob confessions Self diagnosis Lying Unrealistic expectations Excessive administration  Prior authorization Time constraints Free consults at parties Lack of coordination

In this episode of "Doctors Take the Mic," Dr. Gloria Wu discusses the top ten pet peeves of patients.  Dr. Wu will discuss why these are vexing to the patient and address them from the doctor's point of view, explaining why you might experience these challenges in a doctor's office.  1. Wait time 2. No patient records 3. Rude staff 4. No diagnoses 5. No follow ups 6. Too expensive 7. No staff to talk to you 8. No parking 9. No chairs in the waiting room 10. Masking policies 

In this episode of "Doctors Take the Mic," Dr. Gloria Wu discusses the FDA using AI in its new policies.  The use of AI to fast track application process.  Under MAHA, the FDA will investigate the type of ingredients not found in other developed nations versus US.

In this Episode of "Doctors Take the Mic," Dr. Gloria Wu discusses the plans of Silicon Valley companies to expand AI even further and steps taken towards automating our lives using an article from the New York Times written by Kevin Roos.

In the current age of AI, it's hard to get a handle on all the various models and programs being released. In this episode of Doctors Take the Mic, Dr. Gloria Wu breaks down the fundamental features of ChatGPT and Gemini, two of the most popular LLMs, in this beginner-friendly episode. She walks listeners through each platform's core capabilities, from conversation memory and response accuracy to integration options and user interfaces.

Should we or should we not eat fish? Small fish or big fish? What about the environmental impact of eating fish. What about the size of the fish (big fish eat smaller fish, so you are eating more of the food pyramid).  What are the ethics of eating fish?

How do people experience consciousness?  NY Times article by Carl Zimmer, entitled, "Too Many Ideas on What Makes Human Conscious, published May, 6, 2025.  It is an exciting look at what neuroscientists think.  29 theories about human consciousness exist. This podcast talks about the major groups and their thoughts.

Short podcast about the plastics and plastic water bottles.  These plastics are called endocrine disuptors.  Some endocrine-disrupting chemicals (EDCs) have been linked to an increased risk of thyroid cancer. Specifically, certain PFAS (per- and polyfluoroalkyl substances) and other chemicals, like PBDEs (polybrominated diphenyl ethers) and phthalates, have shown a positive association with thyroid cancer risk in studies. 

Dr. Gloria Wu reveals how understanding the brain's "love centers" can transform your marketing strategy. Drawing on neuroscience research and examples from top brands, she shows how AI can help identify what truly motivates your customers—creating connections that drive loyalty and success across healthcare, business, and technology.

div]:bg-bg-000/50 [&_pre>div]:border-0.5 [&_pre>div]:border-border-400 [&_.ignore-pre-bg>div]:bg-transparent [&>div>div>:is(p,blockquote,h1,h2,h3,h4,h5,h6)]:pl-2 [&>div>div>:is(p,blockquote,ul,ol,h1,h2,h3,h4,h5,h6)]:pr-8"> _*]:min-w-0"> In this episode, Dr. Wu explores the connection between brain science and effective leadership. She discusses how great leaders maintain composure during crises and the biological structures that enable empathy. Drawing from her medical leadership experience, Dr. Wu contrasts traditional authoritarian approaches with modern collaborative environments that create better outcomes through emotional awareness and team psychological safety.  

In this fascinating episode, Dr. Gloria Wu delves into groundbreaking research on the biological foundations of empathy. She introduces listeners to the pivotal role of oscillator cells—specialized neurons that synchronize brain activity between individuals during empathetic exchanges. Dr. Wu explains how these cells create neural resonance that allows us to literally "feel with" others, bridging the gap between separate minds. The conversation explores practical applications of this research in healthcare settings, where understanding the oscillator cell mechanism is transforming doctor-patient relationships and treatment outcomes. Join us for an illuminating hour that connects cutting-edge neuroscience with the everyday experience of human connection.

Dr. Gloria Wu discusses innovative wound care using biotechnology bandages made from birth tissue. She explains their value in treating difficult wounds and saving eyesight in severe cases. The episode mentions recent media coverage while emphasizing the healing benefits and introducing a donation program for listeners interested in contributing placental tissue.

Dr. Gloria Wu reveals how Google now processes an astounding 5 trillion searches yearly and explains why healthcare professionals should recognize their patient information as a valuable asset. She discusses how medical practitioners can use data for strategic decisions, competitive advantage, and future financial planning. This episode offers essential insights on why understanding data as an asset class is crucial for healthcare providers seeking to maximize value.

Dr. Gloria Wu offers strategic guidance for investing in the AI healthcare revolution, highlighting opportunities beyond tech giants. She emphasizes leveraging personal healthcare knowledge when evaluating investments, particularly in underutilized medical data and pharmaceutical research tools. Dr. Wu points to resources including university startups, specialized indices, and analytical platforms, while covering promising sectors from cybersecurity to neuroscience research targeting conditions like dementia.

Tech visionary Bill Gates thinks that AI will democratize access to quality healthcare.  AI will get rid of entry level computer jobs but healthcare will still need doctors.   advice within the next decade. The conversation explores how AI technology will increasingly integrate into diagnostic processes and medical decision-making, potentially reshaping traditional healthcare relationships. Gates addresses both the promise and concerns of this technological shift, acknowledging the unprecedented nature of these developments while discussing their potential benefits and challenges. This candid discussion offers listeners a fascinating glimpse into how AI might make healthcare expertise more widely available while raising important questions about the future role of human practitioners in medicine.